|1.||Eltzschig, Holger K: 5 articles (08/2015 - 09/2003)|
|2.||Ravid, Katya: 3 articles (08/2015 - 10/2010)|
|3.||Linden, Joel: 3 articles (11/2012 - 02/2011)|
|4.||Colgan, Sean P: 3 articles (04/2009 - 09/2003)|
|5.||Morello, Silvana: 2 articles (09/2015 - 11/2012)|
|6.||Eckle, Tobias: 2 articles (08/2015 - 01/2014)|
|7.||Bonney, Stephanie: 2 articles (08/2015 - 01/2014)|
|8.||Kron, Irving L: 2 articles (01/2015 - 10/2010)|
|9.||Feoktistov, Igor: 2 articles (09/2014 - 09/2013)|
|10.||Zhang, Qinkun: 2 articles (09/2014 - 09/2013)|
10/01/2010 - "This study tests the hypothesis that the adenosine A(2B) receptor exacerbates the proinflammatory response to lung ischemia-reperfusion injury. "
11/15/2012 - "In vivo hypoxic preconditioning protects from warm liver ischemia-reperfusion injury through the adenosine A2B receptor."
10/01/2010 - "Tissue-derived proinflammatory effect of adenosine A2B receptor in lung ischemia-reperfusion injury."
03/01/2013 - "We tested whether protection against reperfusion injury by ischemic postconditioning (IPost), soluble guanylyl cyclase (sGC) activation and inhibition, adenosine A(2B) receptor (A(2B)AR) agonist, phosphodiesterase type-5 (PDE-5) inhibitor, or mitochondria-targeted S-nitrosothiol (MitoSNO) was affected by a cardiomyocyte-specific ablation of the PKGI gene in the mouse (CMG-KO). "
10/01/2010 - "Adenosine A(2B) receptor knockout → adenosine A(2B) receptor knockout (donor → recipient) and wild-type → adenosine A(2B) receptor knockout, but not adenosine A(2B) receptor knockout → wild-type, chimeras showed significantly improved lung function after ischemia-reperfusion. "
01/01/2014 - "Adenosine A2B receptor modulates intestinal barrier function under hypoxic and ischemia/reperfusion conditions."
10/01/2010 - "An in vivo left lung hilar clamp model of ischemia-reperfusion was used in wild-type C57BL6 and adenosine A(2B) receptor knockout mice, and in chimeras created by bone marrow transplantation between wild-type and adenosine A(2B) receptor knockout mice. "
10/01/2010 - "These results suggest that the adenosine A(2B) receptor plays an important role in mediating lung inflammation after ischemia-reperfusion by stimulating cytokine production and neutrophil chemotaxis. "
01/01/2014 - "As such, the adenosine A2b receptor was shown to be the only one of the adenosine receptors whose cardiac expression is induced by ischemia in both mice and humans and whose function is implicated in ischemic pre- or post-conditioning. "
11/01/2006 - "Initial studies confirmed previous findings indicating selective induction of human adenosine A2B receptor (A2BR) by hypoxia. "
11/01/2006 - "HIF-dependent induction of adenosine A2B receptor in hypoxia."
11/01/2010 - "Hypoxia-inducible adenosine A2B receptor modulates proliferation of colon carcinoma cells."
02/01/2010 - "We also found that the effect of hypoxia on IL-12p70 production was mediated via increased intracellular cAMP levels through the up-regulation of A2b adenosine receptor and the preferential expression of adenosine A2b receptors in hypoxic mDCs was HIF-1 alpha dependent. "
11/01/2001 - "Enprofylline, a selective adenosine A(2B) receptor antagonist, significantly inhibited the increase in plasma levels of Epo in normal mice exposed to hypoxia. "
09/29/2015 - "Adenosine A2B receptor plays a pivotal role in promoting tumor growth. "
04/01/2014 - "Adenosine A(2B) receptor antagonist PSB603 suppresses tumor growth and metastasis by inhibiting induction of regulatory T cells."
12/15/2015 - "The renewed interest in the adenosine A2B receptor (A2BR) subtype can be traced by studies in which the introduction of new genetic and chemical tools has widened the pharmacological and structural knowledge of this receptor as well as its potential therapeutic use in cancer and inflammation- or hypoxia-related pathologies. "
08/15/2011 - "The adenosine A(2B) receptor is of considerable interest as a new drug target for the treatment of asthma, inflammatory diseases, pain, and cancer. "
11/01/2005 - "In addition, we have uncovered several GPCRs, such as neuropeptide receptors, adenosine A2B receptor, P2Y purinoceptor, calcium-sensing receptor and metabotropic glutamate receptors, that are expressed at a significantly higher level in some cancer tissue and may play a role in cancer progression. "
|2.||soluble guanylyl cyclase
|5.||Purinergic P1 Receptors (Adenosine Receptor)
|6.||Adenosine Triphosphate (ATP)
|8.||Adenosine A2A Receptor (Adenosine A2A Receptors)
|9.||Adenosine A1 Receptor
|10.||Interleukin-6 (Interleukin 6)
|3.||Bone Marrow Transplantation (Transplantation, Bone Marrow)
|4.||Transplantation (Transplant Recipients)